ANJESO (MELOXICAM) INJECTION Trademark

Trademark Overview

On Tuesday, October 30, 2018, a trademark application was filed for ANJESO (MELOXICAM) INJECTION with the United States Patent and Trademark Office. The USPTO has given the ANJESO (MELOXICAM) INJECTION trademark a serial number of 88174417. The federal status of this trademark filing is REGISTERED as of Tuesday, June 16, 2020. This trademark is owned by Recro Pharma, Inc.. The ANJESO (MELOXICAM) INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain
anjeso (meloxicam) injection

General Information

Serial Number88174417
Word MarkANJESO (MELOXICAM) INJECTION
Filing DateTuesday, October 30, 2018
Status700 - REGISTERED
Status DateTuesday, June 16, 2020
Registration Number6080999
Registration DateTuesday, June 16, 2020
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Description of MarkThe mark consists of the word "Anjeso" with a curved line extended upward from the "A" from the word "Anjeso" over the "njeso", and the words "(meloxicam)" and "injection" under the word "Anjeso".
Goods and ServicesPharmaceutical preparations for the treatment of pain
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"MELOXICAM INJECTION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 15, 2018
Primary Code005
First Use Anywhere DateThursday, February 20, 2020
First Use In Commerce DateThursday, March 26, 2020

Trademark Owner History

Party NameBAUDAX BIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355
Party NameBAUDAX BIO, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355
Party NameRecro Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
Party NameRecro Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events

Event DateEvent Description
Friday, November 2, 2018NEW APPLICATION ENTERED
Thursday, November 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 27, 2018ASSIGNED TO EXAMINER
Friday, November 30, 2018NON-FINAL ACTION WRITTEN
Friday, November 30, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 30, 2018NON-FINAL ACTION E-MAILED
Monday, December 31, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 19, 2019ASSIGNED TO LIE
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Thursday, January 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 19, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 10, 2019SOU TEAS EXTENSION RECEIVED
Thursday, October 10, 2019SOU EXTENSION 1 FILED
Thursday, October 10, 2019SOU EXTENSION 1 GRANTED
Friday, February 28, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 28, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 28, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 28, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 28, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, October 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 5, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 28, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, May 9, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 16, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, January 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 26, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 22, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, April 22, 2020USE AMENDMENT FILED
Monday, April 27, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, May 8, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 16, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

injection meloxicam anjeso pain treatment preparations pharmaceutical